Intelligence Platform
Patents
Browse 48 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7297488
Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcr
granted patentUS 7285639
Antibody to telomerase reverse transcriptase
granted patentUS 7262288
Nucleic acids encoding human telomerase reverse transcriptase and related homologs
granted patentUS 7056513
Telomerase
granted patentUS 7005262
Methods for detecting nucleic acids encoding human telomerase reverse transcriptase
expired patentUS 6927285
Genes for human telomerase reverse transcriptase and telomerase variants
expired patentUS 6921664
Telomerase
expired patentUS 6808880
Method for detecting polynucleotides encoding telomerase
expired patentUS 6753411
Protection-of-telomere-1 (POT-1) proteins
expired patentUS 6627619
Antisense compositions for detecting and inhibiting telomerase reverse transcriptase
expired patentUS 6617110
Cells immortalized with telomerase reverse transcriptase for use in drug screening
expired patentUS 6593306
Methods for modulation and inhibition of telomerase
expired patentUS 6551774
Diagnostic methods for conditions associated with elevated cellular levels of telomerase a
expired patentUS 6475789
Human telomerase catalytic subunit: diagnostic and therapeutic methods
expired patentUS 6468983
RNase L activators and antisense oligonucleotides effective to treat telomerase-expressing
expired patentUS 6444650
Antisense compositions for detecting and inhibiting telomerase reverse transcriptase
expired patentUS 6391554
Detecting cancerous conditions by assaying for telomerase activity
expired patentUS 6309867
Telomerase
expired patentUS 6294650
Inhibition of mammalian telomerase by peptide nucleic acids
expired patentUS 6261836
Telomerase
expired patentUS 6194206
Use of oligonucleotide telomerase inhibitors to reduce telomere length
expired patentUS 6166178
Telomerase catalytic subunit
expired patentUS 6093809
Telomerase
expired patentUS 6054442
Methods and compositions for modulation and inhibition of telomerase in vitro
expired